HB 1183: Prescription Drug Price Transparency
GENERAL BILL by Bell
Prescription Drug Price Transparency; Prohibits renewal of permits for prescription drug manufacturers & wholesale distributors unless specified requirements are met; provides reporting requirements for entities that engage in wholesale distributions of prescription drugs; provides requirements for notifications by manufacturers of prescription drug price increases; provides reporting requirements by manufacturers of drug prices; prohibits prescription drugs from being included in specified drug formularies; provides penalties & fines for violations; provides reporting requirements for registered pharmacy benefit managers; requires health insurers & HMOs to notify insureds & subscribers of drug formulary changes; requires pharmacy benefit managers to maintain a website for access to net prices of prescription drugs.
Last Action: 3/14/2022 House - Died in Finance & Facilities Subcommittee
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 1/5/2022 | House |
• Filed |
| 1/10/2022 | House |
• Referred to Finance & Facilities Subcommittee • Referred to Appropriations Committee • Referred to Health & Human Services Committee • Now in Finance & Facilities Subcommittee |
| 1/11/2022 | House |
• 1st Reading (Original Filed Version) |
| 3/12/2022 | House |
• Indefinitely postponed and withdrawn from consideration |
| 3/14/2022 | House |
• Died in Finance & Facilities Subcommittee |
